{"name":"Restorbio Inc.","slug":"restorbio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPanZXbGFndUFsQmlWMlZZdEI1ckdLbHJ6akJxM0kxendtRFNKMWRBZmdidE5HMlh6blQwZlk0cENMbngyRXZzWmpJb2R3NjJneGlzYVJnNzVfSHI4cXdVYi1HQkdsUDQzclp2eFNuc0dUbG5xdVpvYlJSNGxWNXRVSG1PVnBQcmNXUDM1WmhEeno4ZDhON2FJRHdvUzdUOThvZHJuYUFwN01sTGR1NGc?oc=5","date":"2023-01-23","type":"pipeline","source":"citybiz","summary":"Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors - citybiz","headline":"Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMDRvYmFiZzZ3RU5HS0ZUSzV1blRsNlNSeEJxOGtwMTdrazFUYWxlbmtKX1FvU3kzVVl0UUdtVnFTXzJYbEFSNTFBcHA3QUMwMk5xNGNXZTZCMGY0eThTbm40UVR5YVdPR3J1Z19SekxzMkxEaVhmVFpyQm9KODZMYzBpeHFub19UMmg0VFE4elllbnp4SW12M2ZHelZZdGN5YmNva1g4MHRNTWhNUjNzMG1NeWdVY2Q0MzRGbWNoS0lqUFk?oc=5","date":"2020-09-16","type":"regulatory","source":"RTTNews","summary":"ARPO To Report Glaucoma Trial Data In Q4, ARDX To Face FDA In April, PFE's Pipeline Update - RTTNews","headline":"ARPO To Report Glaucoma Trial Data In Q4, ARDX To Face FDA In April, PFE's Pipeline Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPU0pLUnpBMVFBbzdrSkhpeVJkclZJVExkYmRTcHF2djJEVERsQ0dBSUVhQ3FtdUdPMFRhb0sxVnZyNzZNSjR2ZWVsOGJkdDJ4di1qZl9FYlVpMmhxNU1YelpGY3lFNEdNdklNWVZlOXFfUG5DT0JHcDd2Ylg3Zlc0SGlEbDIwdnkwaW5rOTlMaGtvOHZpNTRwbnpTX2xncVFySTdoeDVDb3Jwc0FLQlkzeXZ4VXlIcUdWNXRBNXlpVlpyQQ?oc=5","date":"2020-09-15","type":"deal","source":"GlobeNewswire","summary":"Adicet Announces Completion of Merger with resTORbio - GlobeNewswire","headline":"Adicet Announces Completion of Merger with resTORbio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxPVl81cUVJNDM0MnkyeEh5YkdnckpRbm9qWE9VaWtfZlBZM216dWpYeGNocV9iYVNtUzJJRjBqZVNtZy1wZG9McDNocVdjbGhaeXZMaGdWbmhaN1pqa3BpV0NQcjJYT0x0bnhNOXdoNGV3eWtQZXZQWF9rMmlqVDl2N2V5S1BSbDlDVDdnQzNia2QzaUN1S0pGYlRDeFF3cE5RZGhxWTBMajUzWDVLN19OcmRVTEdWdWc3aURyWE5Md21VT1FvaEk0d1pfWnlSc0VkWk5Ub1RwWWk5Q2k4ODJUTGl4Uzg5eFZpcUdEY1N0U3QydFVQSGE3RW1XbEExYWVDN3VCTlQyb1hCU09vNHJnYUlGN1M0SjJyU09Ia293TWQtWV9waUNjMWJxaHVLaHhEOVJUZmVoeWp6ay16dTlOdQ?oc=5","date":"2020-05-28","type":"trial","source":"GlobeNewswire","summary":"resTORbio Announces Initiation of Study to Evaluate if - GlobeNewswire","headline":"resTORbio Announces Initiation of Study to Evaluate if","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNMVdZZUJ0LUttdFR0Wk1Wdl9iT1NaVlN0WEF2VUJqc2N2V1BBTDh4WFdud3NqMzk3M0ljeWdrRDBPRUpTUUhpWnFGTVRwaHdtTmxVTmRjM3lLSVZnNHFwN0dZeEUzVDJYb0JQQ0t2UWpBLWlLbkFrTjdQMnNZNWJXMURrSHg4bFRQblJlbEoxaXUyT2R5eHBIaDdNY2xFM2Rz?oc=5","date":"2019-11-15","type":"pipeline","source":"The Business Journals","summary":"ResTORbio stock plummets on late-stage drug failure - The Business Journals","headline":"ResTORbio stock plummets on late-stage drug failure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxOV1RrcGNCN3JFbFZNRUxFXzJXQmRLMy1mSTJTTEhSRlNfaXhuaWJSMW5qMkw0NHRQLUM4UERBbXFiRk5BbExwdGg3V0pUdjZ1NXA5Wms4akJaZEtHRi15VS1xTS1jMmpGSGEwZXE4c1gzMXVhRERZZ0VIdktKQ0lBaktGVnVnV013bk1iTzBjYjFYb0pLR3poT0p5VzRPbjVCd1MzZDc0WHBHWENOS0lzZjFiS2hFVGhOSVhFRFRndGxVS1BXQll3MC1QT0ZvWWRwNmNxTmJFcXVHMDdFS1FzaVJEeVRVLVJRUl90SzRYamtoNVNIeDhYQ2tUUkdxNGF5RjM4R1JnVjk1b2tMVGprSU15TGp4WUdfbW45M1U1M05sYm03V3loaDVBXzV2TmJzalJnaG5MTFRvMlFO?oc=5","date":"2019-11-15","type":"trial","source":"GlobeNewswire","summary":"resTORbio Announces That the Phase 3 PROTECTOR 1 Trial of - GlobeNewswire","headline":"resTORbio Announces That the Phase 3 PROTECTOR 1 Trial of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQR08wemxMbVpDU2U3OTZ1bFp3dlUxRU9MX2NneWExN1FFSFdkazhvRlcwcjhHOHdJdTJOX1NfUXhxLWNGdWFFX1F1SS04eVVXN2RvdTM1THZiQkQtcFVSbnpZb1NmQ2wtNFUyMVRSOXVqQWJyNmJ1REdqZWtteGdfSEVjNDA4UVA5MUR5NmNibEV0cF9tekxRMzFsa1p6bDM5c3RCQ29DOHcwck01SjVKMS1mcmY4cFp2ajZCV2doa09OT3VJMFFyODh2eGw?oc=5","date":"2017-11-30","type":"pipeline","source":"BioSpace","summary":"Boston’s Anti-Aging Startup resTORbio Scores $40M - BioSpace","headline":"Boston’s Anti-Aging Startup resTORbio Scores $40M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}